CompletedNCT00349973
Dipyridamole or olanzapine for schizophrenia symptoms
About this title
Read the official source — NCT00349973Medication studyAges 18–65United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- BaltimoreSee all locations and recruitment
Study information
Study start dateMay 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 29
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00349973
- Official title
Show the full official title
Clinical Trial of Dipyridamole in Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Did this study involve medication?
Yes. The study involved medication, including Dipyridamole.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
